Strides Pharma Science today reported a consolidated net loss of Rs 4.16 crore for the quarter ended June 30.
The company had posted a net profit of Rs 5.78 crore in April-June 2017, Strides Pharma said in a BSE filing.
Consolidated revenue from operations stood at Rs 663.46 crore for the quarter under review. It was Rs 657.78 crore for the same period a year ago.
Shares of the company were trading at Rs 416.40 per scrip on BSE, up 6.20 per cent from the previous close.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)